Isofol Medical AB (publ) (FRA:5IU)
Germany flag Germany · Delayed Price · Currency is EUR
0.0415
+0.0013 (3.23%)
At close: Feb 20, 2026

Isofol Medical AB Balance Sheet

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
41.9996.16138.15190.53379.45
Short-Term Investments
85----
Cash & Short-Term Investments
126.9996.16138.15190.53379.45
Cash Growth
32.06%-30.40%-27.49%-49.79%226.01%
Accounts Receivable
---0.561.63
Other Receivables
1.422.142.434.425.57
Receivables
1.422.142.434.987.2
Prepaid Expenses
0.990.120.010.390.51
Other Current Assets
---13.857.46
Total Current Assets
129.498.42140.59209.75394.61
Property, Plant & Equipment
--00.091.75
Long-Term Investments
---0.05-
Other Long-Term Assets
----5.01
Total Assets
129.498.42140.6209.89401.36
Accounts Payable
2.732.031.997.8717.74
Accrued Expenses
17.0916.8215.0340.8854.51
Current Portion of Leases
----1.54
Other Current Liabilities
1.090.981.231.799.23
Total Current Liabilities
20.9119.8218.2550.5483.02
Long-Term Leases
----0.11
Other Long-Term Liabilities
0.610.650.910.85-
Total Liabilities
21.5320.4719.1651.3983.13
Common Stock
8.614.954.954.954.95
Additional Paid-In Capital
1,2991,2181,2181,2181,218
Retained Earnings
-1,199-1,145-1,102-1,065-904.32
Comprehensive Income & Other
-00-0
Shareholders' Equity
107.8777.95121.43158.5318.23
Total Liabilities & Equity
129.498.42140.6209.89401.36
Total Debt
----1.65
Net Cash (Debt)
126.9996.16138.15190.53377.8
Net Cash Growth
32.06%-30.40%-27.49%-49.57%233.52%
Net Cash Per Share
0.590.600.861.183.01
Filing Date Shares Outstanding
281.11161.52161.52161.52161.52
Total Common Shares Outstanding
281.11161.52161.52161.52161.52
Working Capital
108.4878.59122.34159.21311.59
Book Value Per Share
0.380.480.750.981.97
Tangible Book Value
107.8777.95121.43158.5318.23
Tangible Book Value Per Share
0.380.480.750.981.97
Machinery
-0.070.070.540.54
Source: S&P Global Market Intelligence. Standard template. Financial Sources.